Anticancer Research: 31 (7)

July 2011; Volume 31,Issue 7

Proceedings of the 14th Annual Meeting of the Society of Biotherapeutic Approaches, December 11, 2010, Fukuoka, Japan.

You have access
Preface
Masamichi Tomonaga

Anticancer Research July 2011, 31 (7) 2409;
You have access
KRAS-induced Actin-interacting Protein: A Potent Target for Obesity, Diabetes and Cancer
TAKAHIRO FUJIMOTO and SENJI SHIRASAWA

Anticancer Research July 2011, 31 (7) 2413-2417;
You have access
Induction of Cytotoxic T Lymphocytes by CEA Peptide-pulsed γδ T-Cells Isolated from Patients with Advanced Cancer
AKIO YAMASAKI, HIDEYA ONISHI, TAKASHI MORISAKI and MITSUO KATANO

Anticancer Research July 2011, 31 (7) 2419-2424;
You have access
Sonodynamic Cancer Therapy: A Non-invasive and Repeatable Approach Using Low-intensity Ultrasound with a Sonosensitizer
HIROTOMO SHIBAGUCHI, HIROFUMI TSURU, MOTOMU KUROKI and MASAHIDE KUROKI

Anticancer Research July 2011, 31 (7) 2425-2429;
You have access
Oral Administration of Lipopolysaccharides for the Prevention of Various Diseases: Benefit and Usefulness
HIROYUKI INAGAWA, CHIE KOHCHI and GEN-ICHIRO SOMA

Anticancer Research July 2011, 31 (7) 2431-2436;
You have access
Lipopolysaccharide IP-PA1 from Pantoea agglomerans Prevents Suppression of Macrophage Function in Stress-induced Diseases
KAZUE NAKATA, HIROYUKI INAGAWA and GEN-ICHIRO SOMA

Anticancer Research July 2011, 31 (7) 2437-2440;
You have access
WT1 Peptide Vaccine Stabilized Intractable Ovarian Cancer Patient for One Year: A Case Report
SATOSHI DOHI, SATOSHI OHNO, YUMIKO OHNO, MASAHIRO TAKAKURA, SATORU KYO, GEN-ICHIRO SOMA, HARUO SUGIYAMA and MASAKI INOUE

Anticancer Research July 2011, 31 (7) 2441-2445;
You have access
Frequency of Myeloid Dendritic Cells Can Predict the Efficacy of Wilms′ Tumor 1 Peptide Vaccination
SATOSHI OHNO, FUMIHIDE TAKANO, YASUYUKI OHTA, SATORU KYO, SUBARU MYOJO, SATOSHI DOHI, HARUO SUGIYAMA, TOMIHISA OHTA and MASAKI INOUE

Anticancer Research July 2011, 31 (7) 2447-2452;
You have access
Oncogenic KRAS Regulates miR-200c and miR-221/222 in a 3D-Specific Manner in Colorectal Cancer Cells
TOSHIYUKI TSUNODA, YASUO TAKASHIMA, YASUHIRO YOSHIDA, KEIKO DOI, YOKO TANAKA, TAKAHIRO FUJIMOTO, TAKASHI MACHIDA, TAKEHARU OTA, MIDORI KOYANAGI, MASAHIDE KUROKI, TAKEHIKO SASAZUKI and SENJI SHIRASAWA

Anticancer Research July 2011, 31 (7) 2453-2459;
You have access
A Possible Clinical Adaptation of CRM197 in Combination with Conventional Chemotherapeutic Agents for Ovarian Cancer
HIROSHI TSUJIOKA, TATSUYA FUKAMI, FUSANORI YOTSUMOTO, TAEKO UEDA, SHOKO HIKITA, YOKO TAKAHASHI, HARUHIKO KONDO, MASAHIDE KUROKI and SHINGO MIYAMOTO

Anticancer Research July 2011, 31 (7) 2461-2465;
You have access
Functional Characterization of Lipopolysaccharide derived from Symbiotic Bacteria in Rice as a Macrophage-activating Substance
TAKESHI KADOWAKI, HIROYUKI INAGAWA, CHIE KOHCHI, MITSUOMI HIRASHIMA and GEN-ICHIRO SOMA

Anticancer Research July 2011, 31 (7) 2467-2476;
You have access
Design, Synthesis and Destructive Dynamic Effects of BODIPY-containing and Curcuminoid Boron Tracedrugs for Neutron Dynamic Therapy
EIJI NAKATA, MASATO KOIZUMI, YOHEI YAMASHITA, KENTA ONAKA, YOSHINORI SAKURAI, NATSUKO KONDO, KOJI ONO, YOSHIHIRO UTO and HITOSHI HORI

Anticancer Research July 2011, 31 (7) 2477-2481;
You have access
Antitumor Effects of CRM197, A Specific Inhibitor of HB-EGF, in T-Cell Acute Lymphoblastic Leukemia
NAOKO KUNAMI, FUSANORI YOTSUMOTO, KENJI ISHITSUKA, TATSUYA FUKAMI, TAKASHI ODAWARA, SADAO MANABE, TOYOKAZU ISHIKAWA, KAZUO TAMURA, MASAHIDE KUROKI and SHINGO MIYAMOTO

Anticancer Research July 2011, 31 (7) 2483-2488;
You have access
Effect of the Gc-derived Macrophage-activating Factor Precursor (preGcMAF) on Phagocytic Activation of Mouse Peritoneal Macrophages
YOSHIHIRO UTO, SYOTA YAMAMOTO, RYOTA TAKEUCHI, YOSHINORI NAKAGAWA, KEIJI HIROTA, HIROSHI TERADA, SHINYA ONIZUKA, EIJI NAKATA and HITOSHI HORI

Anticancer Research July 2011, 31 (7) 2489-2492;
You have access
Differential Expression of mRNA in Human Monocytes following Interaction with Human Colon Cancer Cells
TERUKO HONDA, HIROYUKI INAGAWA and ISAMU YAMAMOTO

Anticancer Research July 2011, 31 (7) 2493-2497;
You have access
Clinical Course of Colorectal Cancer in Patients with Ulcerative Colitis
DAIJIRO HIGASHI, KITARO FUTAMI, YUKIKO ISHIBASHI, YUJI EGAWA, TAKAFUMI MAEKAWA, TOSHIYUKI MATSUI, AKINORI IWASHITA and MASAHIDE KUROKI

Anticancer Research July 2011, 31 (7) 2499-2504;
You have access
Combinatorial Cytotoxicity of Gemcitabine and Cytokine-activated Killer Cells in Hepatocellular Carcinoma via the NKG2D-MICA/B System
TAKASHI MORISAKI, HIDEYA ONISHI, NORIHIRO KOYA, AKIFUMI KIYOTA, HIROTO TANAKA, MASAYO UMEBAYASHI, TOSHITATSU OGINO, IORI NAGAMATSU and MITSUO KATANO

Anticancer Research July 2011, 31 (7) 2505-2510;
You have access
Novel Complementary Peptides to Target Molecules
HIDECHIKA OKADA, MASAKI IMAI, FUMIKO ONO, ALAN OKADA, TOYOHIRO TADA, YUKA MIZUE, KEIJI TERAO and NORIKO OKADA

Anticancer Research July 2011, 31 (7) 2511-2516;
You have access
Decreased Expression of Claudin-1 in Rectal Cancer: A Factor for Recurrence and Poor Prognosis
TAKEFUMI YOSHIDA, TETSUSHI KINUGASA, YOSHITO AKAGI, AKIHIKO KAWAHARA, KANSAKAR ROMEO, ICHITAROU SHIRATSUCHI, YASUHIKO RYU, YUKITO GOTANDA and KAZUO SHIROUZU

Anticancer Research July 2011, 31 (7) 2517-2525;
You have access
Sonodynamic Therapy with 5-Aminolevulinic Acid and Focused Ultrasound for Deep-seated Intracranial Glioma in Rat
TADAHIRO OHMURA, TAKEO FUKUSHIMA, HIROTOMO SHIBAGUCHI, SHIN YOSHIZAWA, TOORU INOUE, MASAHIDE KUROKI, KAZUNARI SASAKI and SHIN-ICHIRO UMEMURA

Anticancer Research July 2011, 31 (7) 2527-2533;
You have access
KRAS-mediated Up-regulation of RRM2 Expression Is Essential for the Proliferation of Colorectal Cancer Cell Lines
YASUHIRO YOSHIDA, TOSHIYUKI TSUNODA, KEIKO DOI, YOKO TANAKA, TAKAHIRO FUJIMOTO, TAKASHI MACHIDA, TAKEHARU OTA, MIDORI KOYANAGI, YASUO TAKASHIMA, TAKEHIKO SASAZUKI, MASAHIDE KUROKI, AKINORI IWASAKI and SENJI SHIRASAWA

Anticancer Research July 2011, 31 (7) 2535-2539;
You have access
Expression of IGF-1 and IGF-1R and Their Relation to Clinicopathological Factors in Colorectal Cancer
ICHITAROU SHIRATSUCHI, YOSHITO AKAGI, AKIHIKO KAWAHARA, TETSUSHI KINUGASA, KANSAKAR ROMEO, TAKEFUMI YOSHIDA, YASUHIKO RYU, YUKITO GOTANDA, MASAYOSHI KAGE and KAZUO SHIROUZU

Anticancer Research July 2011, 31 (7) 2541-2545;
You have access
Relationship between Ulcerative Colitis Patients Treated with Leukocytapheresis and Ulcerative Colitis-associated Colorectal Cancer
TETSUSHI KINUGASA, YOSHITO AKAGI, KENTA MUROTANI, KANSAKAR ROMEO, TAKEFUMI YOSHIDA, YASUHIKO RYU, ICHITAROU SHIRATUCHI and KAZUO SHIROUZU

Anticancer Research July 2011, 31 (7) 2547-2552;
You have access
Assessment of HB-EGF Levels in Peritoneal Fluid and Serum of Ovarian Cancer Patients using ELISA
SHOKO HIKITA, FUSANORI YOTSUMOTO, TATSUYA FUMAKI, SHINJI HORIUCHI, AYAKO SANUI, KOHEI MIYATA, SUNG OUK NAM, HIROSHI TSUJIOKA, TAEKO UEDA, KYOKO SHIROTA, TOSHIYUKI YOSHIZATO, KAZUHIRO MAEDA, TOYOKAZU ISHIKAWA, YOSHINOBU OKUNO, MASAHIDE KUROKI, EISUKE MEKADA and SHINGO MIYAMOTO

Anticancer Research July 2011, 31 (7) 2553-2559;
You have access
Efficiency of Antimicrobial Defense: Molecular Flexibility of Natural Defensin and Artificial Bis-quaternary Ammonium Compound
KAZUTO OHKURA, YASUO SHINOHARA and HITOSHI HORI

Anticancer Research July 2011, 31 (7) 2561-2564;

Main menu

User menu

Search

Table of Contents

Proceedings of the 14th Annual Meeting of the Society of Biotherapeutic Approaches, December 11, 2010, Fukuoka, Japan.

In this issue